CNOT6L inhibitors represent a class of chemical compounds designed to target and modulate the activity of the CNOT6L protein. CNOT6L is a component of the CCR4-NOT complex, which is a multi-subunit protein complex involved in post-transcriptional regulation of gene expression. The CCR4-NOT complex plays a central role in mRNA decay, mRNA deadenylation, and the control of mRNA stability. CNOT6L, specifically, belongs to the exonuclease subunit of this complex and functions in the degradation of mRNA by removing the poly(A) tail from mRNA molecules. Inhibitors of CNOT6L are developed to interfere with its enzymatic activity or other functions, which can potentially impact the regulation of mRNA stability and gene expression.
The mechanisms by which CNOT6L inhibitors function can vary based on their chemical structures and binding properties. Some inhibitors may directly bind to the CNOT6L protein, preventing its exonuclease activity or its interactions with other components of the CCR4-NOT complex. Others may modulate the stability or conformation of CNOT6L, affecting its ability to participate in mRNA deadenylation and degradation processes. By inhibiting CNOT6L, these compounds have the potential to influence the post-transcriptional control of gene expression, as mRNA decay and stability are critical aspects of gene regulation. Ongoing research in this field aims to elucidate the precise mechanisms and downstream effects of CNOT6L inhibition, furthering our understanding of its role in cellular biology and mRNA metabolism.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D, known for inhibiting RNA synthesis, could potentially affect CNOT6 expression by altering transcriptional processes. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin, a potent inhibitor of RNA polymerase II, might impact CNOT6 expression through its effects on mRNA synthesis. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Cordycepin, a nucleoside analog, may modulate CNOT6 expression by interfering with RNA transcription and processing. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB, an inhibitor of RNA polymerase II, could influence CNOT6 expression by affecting transcription elongation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, might alter CNOT6 expression as part of its role in modulating chromatin structure and gene expression. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Leptomycin B, an inhibitor of nuclear export, may affect CNOT6 expression by impacting mRNA transport and cellular localization. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $52.00 $125.00 $182.00 | 11 | |
Homoharringtonine, an inhibitor of protein synthesis, could potentially modulate CNOT6 expression through its effects on translation initiation. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Puromycin inhibits protein synthesis, might influence CNOT6 expression by disrupting peptide chain elongation. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide, known for inhibiting eukaryotic protein synthesis, may impact CNOT6 expression by affecting translational processes. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin, a protein synthesis inhibitor, could alter CNOT6 expression by its action on peptide chain elongation and translation. | ||||||